Bladder Cancer FRCR CO2A Flashcards

1
Q

What are the types of primary malignant bladder cancer?

A

Transitional Cell Carcinoma 90%
Sq Cell Carc 5%
Adenocarcinoma 1-2 %
Small cell carcinoma
others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the male to female ratio for incidence of BC ?

A

5:2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the RFs for BC?

A

Smoking (2 naphthylamine, polycyclic aromatase hydrocarbons)
Passive smoking
Occupation: petroleum, rubber, dye and paint (chlorinated hydrocarbons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the genetic syndromes a/w BC?

A

RB1 and Lynch syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does family history of BC affect its risK?

A

1st degree relative doubles an individual’s risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

is any screening recommended for BC detection

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which site of bladder is MC affected ?

A

The base of bladder and multiple tumors are frequent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which NMIBC should be considered as high grade?

A

CIS, High grade G3 T1 lesions, 20% of NMIBC will become muscles invasive and recc risk is 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what investigations for hematuria of unknown case

A

Urinanalysis for cytology and culture
Flexible white light cystoscopy,
In NMIBC, blue light cystoscopy, dissease appears red and normal tissue as blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Whats the mc clinical presentation for BC

A

Painless hematuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What investigations should be done after confirmation of BC diagnosis?

A

TURBT
Pelvic MRI or CT
CT chest abdomen pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

is bone scan routinely done

A

no, only if symptoms or raised Ca or ALP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

is there any role of PET

A

limited use bcoz of interference from urinary excretion of contrast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what should be included in histology report ?

A
  1. location and grade
  2. Depth of invasion
  3. CIS present/absent
  4. LVSI
  5. aberrant histology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is important in specimen

A

presence of detrusor muscle, its absence means incomplete resection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the chances of LN spread

A
  1. 20 % for lamina propria involvment
  2. 30% for superficial muscle involvement
  3. 60% for full thickness muscle involvment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the treament of NMIBC

A

TURBT followed by single dose of perioperative intravesical chemotherapy, reduces rist by 11.7% compared to TURBT alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which intravesical agent is superior to ChT

A

BCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are other chemo intravesical options?

A

Doxorubicin and epirubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

which agent is commonly given in UK as intravesical chemo?

A

Mitomycin C 20 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are C/I for intravesical therapy

A

suspected or confirmed cases of perforation following TURBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is recommeded duration of Rx with BCG

A

1 year for intermediate risk, 1-3 years for high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are absolute C/I for BCG

A

difficult catherisation or during 14 days of TURBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are relative C/I for BCG

A

immunosuppression or asymptomatic bacteriuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what follow up timing is recommened for NMIBC post treatment?

A

Cystoscopy and urine cytology initially 3 months post TURBT, should be followed up for 5 years after low risk disease and life long for intermediate and high risk disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what is the treament for MIBC T2-T4a N0/Nx M0

A

Radical Cystectomy (RC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what things should be looked at before RC

A

patient PS, comorbidities and their wish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When is RC Treatment of choice

A

high risk pts, defined as cT4, CIS, multifocal, incomplete TURBT, HDUN and fit for surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when is definitive CRT recommended

A

not fit for surgery and wish for bladder preservation

25
Q

whats the advantage of extended b/l pelvic lymphadenectomy

A

better 5 years survial than stand LND

25
Q

which pts should be given option of bladder preservation?

A

medically fit and intermediate RFs cT2-T3, no CIS, unifocal, complete TURBT and no HDUN

26
Q

What does RC involve

A

cystoprostatectomy for mend and anterior exenteration for women with urinary diversion using a bowel segment

27
Q

what is poor prognostic feature

A

positive nodal status

28
Q

what are complications of RC

A

bleeding infection TE lymphocele formation anastomotic leakage bowel obstruction and sexual dysfunction

29
Q

for how long surveillance is mandatory for MIBC post treatment

30
Q

which organs are commonly sites of metastasis for BC

A

lungs, liver bones

31
Q

what is the rationale for NACT

A

addressing micrometastases and downstaging the primary tumor

32
Q

who are the candidates for NACT

A

all fit surgical candidates with adequaate renal function

33
Q

what are recommended chemo regimens for NACT

A

MVAC and Gem Cis

34
Q

when is response evaluation done with NACT

A

after 2 cycles, if good response, chemo for 3 to 4 cycles

35
Q

what gap should be given between chemo completion and surgery

A

atleast 4 weeks

36
Q

whats the role of adjuvant chemo?

A

survival benefit with cisplatin based regimens
NACT remains SOC however adjuvant for someone who missed NACT or high volume nodal disease or extravesical spread at RC

37
Q

what is trimodality bladder preseving strategy

A

TURBT followed by CRT (with early salvage cystectomy for recurrent disease)

38
Q

how is trimodality strategy compared to RC

A

similar survival rates

39
Q

what are important prognostic factors post trimodality therapy

A

pts age
tumor size
response to RT
HDUN and
completeness of TURBT

40
Q

what is split course regimen

A

Maximal TURBT and CRT to 40 Gy with cis and 5 FU given before repeat cystoscopy and biopsy: complete ressponse in 72% of pts who proceed to condolidation CRT to total dose of 64 Gy

41
Q

what has BCON study shown

A

survival benefit with hypoxic modification in addition to standard RT

42
Q

how long surveillance is required post cystectomy

A

3 monthly for first year, six monthly for 2nd year then annually

CT at 6 and 12 months and then annually

43
Q

how should NMIBC recurrence be managed

A

for 1st prsentation with TURBT and Intravesical therapy, if recurrent cystectomy

44
Q

What things should be kept in mind while planning RT for BC

A

empty rectum and empty bladder, unless partial bladder irradiation is planned

44
Q

How is RT simulation for BC done

A

supine, flat couch arms folded across the chest

45
Q

where should skin tatoos be placed

A

anteriorly over the pubic symphisis and laterally over the iliac crests to prevent lateral rotation

46
Q

what should be planning CT field

A

3 mm slice bottom of the ischial tuberosities to 3 cm above the dome of bladder or bottom of L5, whichever is higher

47
Q

What CTV includes

A

visible known tumor and normal bladder,

48
Q

what is margin from CTV for PTV

A

15 mm around normal bladder and 20 mm around tumor

49
Q

IS nodal irradiation frequently done in UK even in high risk of nodal disease

A

no, because the benefits are unclear

50
Q

what direction beams are given

A

one anterior and two posterior oblique wedged fields

51
Q

What RT dose is frequently used for radical Rx

A

64 Gy/32# over 6.5 weeks or 55 Gy/20# over 4 weeks

52
Q

how is T4b or N+ disease treated?

A

Many consider it systemic disease and treat with 4 to 6 cycles of systemic therapy, if good response consolidation RT to the bladder and possibly pelvic nodes

53
Q

if nodal irradiation is planned, what bladder protocol should be followed and why

A

full bladder to avoid high doses to bowel

53
Q

what is EORTC defined fitness for cisplatin

A

GFR > 60 ml/min and PS 0-1, uretric shunt should be placed first before systemic Rx is planned for obstruction

53
Q

what treatment for PS >2

53
Q

can carboplatin replace cisplatin for cisplatin fit pts

A

no, OS is inferior with Carboplatin

53
Q

what is 1st Line Treatment for Cisplatin ineligible pts in recurrent/metastatic setting ?

A

Pembrolizumab and enfortumab vedotin-ejfv1

53
Q

what is 1st Line Treatment for Cisplatin eligible pts in recurrent/metastatic setting ?

A

Pembrolizumab and enfortumab vedotin-ejfv1

54
Q

what are other 1st Line Treatment for Cisplatin eligible/ineligible pts in recurrent/metastatic setting ? except pembro and enfortumab vedotin?

A

Gemcitabine and cisplatin4 (category 1) followed by avelumab maintenance therapy (category 1)a,13
* Nivolumab, gemcitabine, and cisplatin (category 1) followed by nivolumab maintenance therapy14

55
Q

what are Palliative RT doses for BC

A

21 Gy/3# or 36 Gy/10# or 30 Gy/10#

56
Q

if Rx to the whole pelvis with parallel fields is required, what dose should be used

A

30 Gy/ 10#

57
Q

if low volume bladder only is being treated, what dose should be used

58
Q

is Single Fraction of 8 Gy effective

A

yes for hematuria and for PS > 2

59
Q

what palliative RT dose should be considered for Rx with CT planning

A

35 Gy/10# or 36 Gy/ 6#